| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Department of Psychology, Carnegie Mellon University; Department of Otolaryngology, Section of Allergy/Immunology-Department of Pediatrics, Children’s Hospital of Pittsburgh and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Address reprint requests to: Sheldon Cohen, Department of Psychology, Carnegie Mellon University, Pittsburgh, PA 15213. E:mail: scohen{at}cmu.edu
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMETHODSRESULTSDISCUSSIONACKNOWLEDGMENTSREFERENCES |
|---|
METHODS: After completing a measure of psychological stress, 55 subjects were experimentally infected with an influenza A virus. Subjects were monitored in quarantine daily for upper respiratory symptoms, mucus production, and nasal lavage levels of interleukin (IL)-6.
RESULTS: Higher psychological stress assessed before the viral challenge was associated with greater symptom scores, greater mucus weights, and higher IL-6 lavage concentrations in response to infection. The IL-6 response was temporally related to the two markers of illness severity, and mediation analyses indicated that these data were consistent with IL-6 acting as a major pathway through which stress was associated with increased symptoms of illness. However, this pattern of data is also consistent with increases in IL-6 occurring in response to tissue damage associated with illness symptoms.
CONCLUSIONS: Psychological stress predicts a greater expression of illness and an increased production of IL-6 in response to an upper respiratory infection.
Key Words: cytokines, • IL-6, psychological stress, • infection, • upper respiratory illness, • influenza.
Abbreviations: IL-6 = interleukin-6;; HI = hemagglutination-inhibition;; TNF = tumor necrosis factor;; PSS-10 = 10-item Perceived Stress Scale.
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONACKNOWLEDGMENTSREFERENCES |
|---|
Recent studies reported that psychological stressors acutely activate the production of the proinflammatory cytokine IL-6 (11). In response to infection, IL-6 release is thought to be mediated by glucocorticoids, thus providing a hypothetical pathway by which stressors (via their induction of glucocorticoid production) could control cytokine release (12). In addition, IL-6 triggers additional release of glucocorticoids, possibly exacerbating the stress response by positive feedback modulation. At least one source of IL-6 is epithelial cells as evidenced by their production of IL-6 in vitro and in vivo when exposed to rhinovirus (13). Because a local increase in the concentration of this proinflammatory cytokine precedes the development of acute signs and symptoms of illness, it has been implicated as a mediator in the pathway for symptom expression. In fact, IL-6 concentrations in nasal secretions were associated with upper respiratory symptoms among persons infected with influenza A virus [A/Texas and A/Kawasaki (14, 15)] and rhinovirus [strain Hanks’ and type 39 (13)].
In the present study, we address the hypothesis that IL-6 production in response to influenza A virus infection represents a viable pathway through which psychological stress influences the severity of illness. To achieve that goal, we measured levels of psychological stress in a group of adult subjects before infecting them with an influenza A virus, and measured self-reported respiratory symptoms, mucus weights, and local IL-6 concentrations on the day before and for 7 days after virus exposure. We tested the hypotheses that the level of psychological stress predicts the severity of illness and also the magnitude of the cytokine response, and then examined the data for evidence of IL-6 mediation of the association between stress and illness.
|
METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONACKNOWLEDGMENTSREFERENCES |
|---|
Design
The study was run in two approximately equal cohorts, one in September and the other in December. Subjects were quarantined for a total of 8 days in a local hotel. During the first 24 hours of quarantine (before viral exposure), they had a complete physical examination, a nasal wash culture for Kawasaki A virus and each woman had a pregnancy test. Subjects were excluded if there was any indication of recent or current upper respiratory infection, illness, or pregnancy. On that day, they also completed the Perceived Stress Scale and recorded baseline respiratory symptoms. Expelled nasal secretions were collected and weighed and a nasal lavage was performed for baseline viral culture and assay of local IL-1, IL-6, and tumor necrosis factor (TNF) concentrations.
At the end of the first 24 hours of quarantine, subjects were given nasal drops containing an infectious dose (0.25 ml inoculum containing approximately 107 TCID50) of a safety-tested clinical isolate of influenza A/Kawasaki/86 H1N1 (wild type, lot E-262; NIH). Beginning 48 hours after inoculation and continuing for the remainder of the quarantine period, subjects were treated twice a day according to a randomization code with either oral rimantadine HCL (Flumadine, 100-mg tablets; Forest Pharmaceuticals, St Louis, MO), or an identically appearing lactose placebo. This was done in accordance with the protocol of the parent NIH funded study from which this population was drawn (16). On all days, nasal lavages for virus culture and assay of cytokine levels were collected, subjects rated the severity of their respiratory symptoms, and nasal mucus production was measured. Approximately 28 days after challenge, a blood sample was collected for serological testing of HI antibody titer to the challenge virus. All investigators were blinded to treatment and scores on the Perceived Stress Scale.
Perceived Stress Scale
The 10-item Perceived Stress Scale (PSS-10) was used to assess the degree to which situations in life are perceived as stressful (reliability Cronbach’s 
= .87 in this sample). Items in the PSS-10 were designed to tap how unpredictable, uncontrollable, and overloading respondents find their lives (17).
Criteria for Infection
Because we were interested in the role of stress and proinflammatory cytokines in triggering symptomatology, only the 55 subjects infected with the virus were included in our analyses. Subjects were classified as infected if the challenge virus was isolated in nasal washings on any of the 7 postinoculation study days or if there was at least a 4-fold increase in virus-specific HI antibody titer. For culture, samples of lavage fluid were inoculated onto Madin-Darby canine kidney cell monolayers in triplicate and the virus was identified by hemadsorption. The first isolate was confirmed to be influenza by immunofluorescent testing (18). Antibody titers were assessed by hemagglutination-inhibition testing using standard techniques (19).
Signs and Symptoms
At the end of each day of quarantine, subjects rated the severity of eight respiratory symptoms (sneezing, nasal discharge, nasal congestion, sore throat, cough, malaise, headache, chilliness) during the previous 24 hours. Ratings ranged from 0 (none) to 3 (severe) for each symptom. The symptom scores were summed within day. Mucus production was assessed by collecting used tissues in sealed plastic bags. The bags were weighed and the weight of the tissues and bags subtracted. Mucus weights were also summed within day. Because the distribution of mucus weights was skewed, we used the log10 in all analyses.
Proinflammatory Cytokines
Cytokines were assayed using ELISAs obtained from Endogen (Woburn, MA). All had inter- and intraassay variabilities of <10%. The lower limit of detectability was 5 pg/ml for TNF, 1 pg/ml for IL-1ß, and 1 pg/ml for IL-6. We could not reliably detect either IL-1ß or TNF in nasal secretions at baseline or on any day after virus inoculation. Hence, the data analysis was confined to IL-6 levels. Because the distribution of IL-6 was skewed, we used the log10 in all analyses.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONACKNOWLEDGMENTSREFERENCES |
|---|
of p < .20). Therefore, body mass was included in all analyses as a covariate.
Statistical Model.
The primary dependent variables were the total scores for each disease outcome summed across the 7 days after inoculation. We also report separate analyses for each outcome on each day of the trial. In all analyses the postinoculation symptoms, mucus weights, and cytokine levels are adjusted for baseline. In bivariate correlations, this adjustment is accomplished by using residualized change scores—regressing the postchallenge total of each outcome on its corresponding baseline level and calculating the residual score. The residual score is the difference between what one would predict from baseline and the observed score. Identical adjustment is accomplished in the multiple regression analyses by including baseline measures as covariates.
The major hypotheses were tested using multiple regressions. Independent variables entered into the regression equations included psychological stress (treated as a continuous variable), receipt of active medication (yes or no), followed by the stress-by-medication interaction. Symptoms, mucus weights, and IL-6 levels were analyzed as separate dependent variables. The baseline (day 0) levels of the outcome variables were controlled for by forcing the appropriate (same as outcome) baseline measure into the regression before the independent variables. Body mass was similarly covaried in all analyses. The regression analysis allowed us to maintain the continuous character of psychological stress as well as to directly and simply test hypotheses about potential pathways. To provide an estimate of the effect size of each association, we present the appropriate partial correlation with each F statistic. The partial correlation represents the association between stress and a specific outcome after controlling for baseline, receipt of active medication or not, and body mass.
Figures 1 through 3 summarize the associations between psychological stress and each of the three outcome variables. To simplify the presentation, psychological stress was dichotomized in these figures (median = 14). However, all of the analyses we report treated stress as a continuous variable.
|
|
|
Psychological Stress and Mucus Weights
The relation between psychological stress and mucus weights is depicted in Figure 2. As with symptoms, mucus weights increased sharply to peak 2 to 3 days after inoculation and then decreased to their baseline level by day 7. Mucus weights after inoculation (controlling for baseline) increased with increasing levels of psychological stress (F(1,50) = 6.3, p < .02; r = .33). Mucus weights were not associated with either medication or the psychological stress-by-medication interaction. Analyses of individual days indicate relations between stress and mucus weights on days 2 (F(1,50) = 8.7, r = .38, p < .01), 3 (F(1,50) = 7.1, r = .35, p < .01), and 4 (F(1,50) = 9.7, r = .40, p < .01). There were no associations on other days.
Psychological Stress and IL-6
The relation between psychological stress and local IL-6 concentration is depicted in Figure 3. A sharp increase in IL-6 levels occurred over the first 2 days after inoculation, but unlike the pattern for symptoms and mucus weights, IL-6 levels remained slightly elevated not returning to baseline levels during the period of follow-up. IL-6 levels after inoculation (controlling for baseline) increased with increasing psychological stress scores (F(1,50) = 5.8, p < .02, r = .32). IL-6 levels were not associated with either medication or the psychological stress-by-medication interaction. Analyses of individual days indicate that IL-6 increases with increased stress on days 2 (F(1,50) = 4.9, r = .30, p < .04), and 4 (F(1,50) = 6.5, r = .34, p < .02). Marginal associations occurred on days 3 and 5 (in both cases F(1,50) = 3.1, r = .24, p < .09). There were no associations on other days.
There was a 4.7-fold difference in pg/ml between those less than (7.4 pg/ml) and more than (35.0 pg/ml) the median on perceived stress on day 2 (largest difference). Summing across the 7 postinoculation days, there was a 2.3-fold increase (61.8 pg/ml for those below the median and 140.1 pg/ml for those above). The magnitude of these differences is consistent with the IL-6 changes in drug treatment trials with documented physiological effects (20, 21).
IL-6 as a Pathway Linking Psychological Stress to Disease
Although the correlational nature of these data does not allow for a direct test of whether the documented association between stress and disease expression is mediated by IL-6, we can examine the extent to which such mediation is consistent with the data. Conditionally, our hypothesis is consistent if: a) stress is associated with the proposed mediator; b) the proposed mediator is associated with the outcome; and c) the relation between stress and outcome is substantially reduced by partialing the effect of the mediator out of the correlation between stress and the outcome (22). Condition 1 is satisfied by our observation that persons with higher levels of psychological stress produce more IL-6 (r = .32, p < .02), whereas condition 2 is satisfied by the significant correlations calculated for IL-6 and symptoms (r = .38, p < .005) and for IL-6 and mucus weights (r = .46, p < .001). Finally, adding total postinoculation IL-6 levels as a covariate in the analyses reduced the percent variance in symptoms explained by perceived stress from 8.8% in the original analysis to 3.7%, and reduced the percent explained variance in mucus weight from 8.2% to 2.7%. Moreover, perceived stress no longer predicts symptoms (F(1,49) = 2.8, p > .10) or mucus weights (F(1,49) = 2.5, p > .10) after IL-6 was entered as a covariate. Thus, after partialing out the effect of IL-6, the effect size of psychological stress on symptoms was reduced by 58% (1–3.7/8.8) and that of psychological stress on mucus weight by 67% (1–2.7/8.2). These results satisfy condition 3 and show that our data are consistent with the hypothesis that IL-6 is a primary mediator of the relationship between stress and illness severity.
Similar analyses were conducted separately for days 2, 3, and 4. As reported earlier, stress was associated with symptoms, mucus weights, and IL-6 on these days. When IL-6 was partialed out of the relation between stress and symptoms, the effect size was reduced 92% (1–0.7%/8.7%) on day 2, 65% (1–2.8%/8.0%) on day 3, and 94% (1–0.3%/5%) on day 4. When IL-6 was partialed out of the relation between stress and mucus weights, the effect size was reduced 72% (1–3.0%/10.8%) on day 2, 65% (1–3.3%/9.4%) on day 3, and 44% (1–8.1%/14.4%) on day 4.
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONACKNOWLEDGMENTSREFERENCES |
|---|
We also found that during the early period of influenza A virus infection, the local concentration of the proinflammatory cytokine IL-6 varied in phase with the symptoms and mucus production provoked by the infection. This observation is consistent with earlier work showing a temporal relationship between IL-6 levels and symptoms for upper respiratory infection with rhinovirus (13) and with influenza A virus (14), and suggests that IL-6 production may represent a common pathway through which upper respiratory virus infection is translated into signs and symptoms. Furthermore, persons reporting greater psychological stress before inoculation responded to infection with a greater concentration of this cytokine in their nasal secretions. This association between stress and cytokine production is consistent with earlier work in both animals and humans (24). It is noteworthy, however, that in our data the association between baseline levels of IL-6 and psychological stress did not reach significance (r = .24, p < .09). It was the IL-6 response to the viral infection (controlling for baseline) that was significantly higher for those reporting greater psychological stress. That the relation between stress and IL-6 was marginal without the stimulus of the infectious challenge is probably attributable to a restricted range of variance in IL-6 levels under basal conditions. It could also be attributable to greater measurement error (and hence less statistical power) when basal levels are based on only one sample. A similar point could be made about several marginal effects we found when looking at individual postinoculation days of the trial.
We hypothesized that increased nasal secretory production of IL-6 might mediate the relationship between increased psychological stress and increased signs and symptoms of illness. Our analyses suggest that most of the effect of psychological stress on symptoms and of psychological stress on mucus weights could be accounted for by changes in IL-6. However, it is possible that IL-6 itself is not the causal link but rather just a marker (covariate) of other unassayed proinflammatory chemicals elevated during the course of experimental infection. For example, Hayden et al. (14) reported that interferon and IL-6 levels (but not TNF, IL-8, IL-1, or IL-2) were both increased early in the course of the infection, and that both correlated with viral titers, temperature, mucus production and symptom scores. There is also an issue of the correlational nature of the mediational analysis. Although consistent with the hypothesis that the association of stress and illness are mediated by IL-6, the data do not permit causal inference. For example, this pattern of data is also consistent with increases in IL-6 occurring in response to tissue damage associated with illness symptoms. Even with these reservations, this is the first study to provide evidence consistent with the hypothetical model that psychological stress influences upper respiratory infectious illness through a biological pathway.
Finally, there is the question of why symptoms and mucus weights decrease at faster rates than IL-6 concentrations. As mentioned earlier, proinflammatory cytokines are both a product of and producer of the inflammatory process. The slower return of IL-6 levels in the high PSS group (Figure 3) could be a residual marker of the tissue damage occurring in the individuals with greater signs and symptoms of illness.
|
ACKNOWLEDGMENTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONACKNOWLEDGMENTSREFERENCES |
|---|
We are indebted to Janet Schlarb, James Seroky, Cuneyt Alper, Gregory Allen, Stephanie Moody, Patricia Fall, and Susan Strelinski for their assistance in conducting this study. We acknowledge Frederick Hayden and Carolyn Crump for performing and interpreting the virological aspects of the study, Asha Patel for performing the cytokine assays, and Bruce S. Rabin for his comments on an earlier draft.
Received for publication August 12, 1998.
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONACKNOWLEDGMENTSREFERENCES |
|---|
This article has been cited by other articles:
 |
|
 |
|
  L. Nielsen, T. Curtis, T. S. Kristensen, and N. Rod Nielsen What characterizes persons with high levels of perceived stress in Denmark? A national representative study Scand J Public Health, June 1, 2008; 36(4): 369 - 379. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Muennig, H. Jia, R. Lee, and E. Lubetkin I Think Therefore I Am: Perceived Ideal Weight as a Determinant of Health Am J Public Health, March 1, 2008; 98(3): 501 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Geronimus, M. Hicken, D. Keene, and J. Bound "Weathering" and Age Patterns of Allostatic Load Scores Among Blacks and Whites in the United States Am J Public Health, May 1, 2006; 96(5): 826 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Coussons-Read, M. L. Okun, M. P. Schmitt, and S. Giese Prenatal Stress Alters Cytokine Levels in a Manner That May Endanger Human Pregnancy Psychosom Med, July 1, 2005; 67(4): 625 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Schwab, R. Fan, Q. Zheng, L. P. Myers, P. Hebert, and S. B. Pruett Modeling and Predicting Stress-Induced Immunosuppression in Mice Using Blood Parameters Toxicol. Sci., January 1, 2005; 83(1): 101 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Bloch, L. Neeleman, and L. M. Aleamoni The Salient Stressor Impact Questionnaire (SSIQ): A Measurement of the Intensity and Chronicity of Stress Assessment, December 1, 2004; 11(4): 342 - 360. [Abstract] [PDF]
|
|
|
|
|
|
D. M. Golden-Kreutz, M. W. Browne, G. M. Frierson, and B. L. Andersen Assessing Stress in Cancer Patients: A Second-Order Factor Analysis Model for the Perceived Stress Scale Assessment, September 1, 2004; 11(3): 216 - 223. [Abstract] [PDF]
|
|
|
|
 |
|
 A. D. Ong, C. S. Bergeman, and T. L. Bisconti The Role of Daily Positive Emotions During Conjugal Bereavement J. Gerontol. B. Psychol. Sci. Soc. Sci., July 1, 2004; 59(4): P168 - P176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cohen, W. J. Doyle, R. B. Turner, C. M. Alper, and D. P. Skoner Childhood Socioeconomic Status and Host Resistance to Infectious Illness in Adulthood Psychosom Med, July 1, 2004; 66(4): 553 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Kroenke, S. E. Hankinson, E. S. Schernhammer, G. A. Colditz, I. Kawachi, and M. D. Holmes Caregiving Stress, Endogenous Sex Steroid Hormone Levels, and Breast Cancer Incidence Am. J. Epidemiol., June 1, 2004; 159(11): 1019 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Coker, S. Bond, M. M. Madeleine, K. Luchok, and L. Pirisi Psychosocial Stress and Cervical Neoplasia Risk Psychosom Med, July 1, 2003; 65(4): 644 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Gidron, H. Gilutz, R. Berger, and M. Huleihel Molecular and cellular interface between behavior and acute coronary syndromes Cardiovasc Res, October 1, 2002; 56(1): 15 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Kohut, M. M. Cooper, M. S. Nickolaus, D. R. Russell, and J. E. Cunnick Exercise and Psychosocial Factors Modulate Immunity to Influenza Vaccine in Elderly Individuals J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2002; 57(9): M557 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cohen, N. Hamrick, M. S. Rodriguez, P. J. Feldman, B. S. Rabin, and S. B. Manuck Reactivity and Vulnerability to Stress-Associated Risk for Upper Respiratory Illness Psychosom Med, March 1, 2002; 64(2): 302 - 310. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. J. WRIGHT, S. COHEN, V. CAREY, S. T. WEISS, and D. R. GOLD Parental Stress as a Predictor of Wheezing in Infancy . A Prospective Birth-Cohort Study Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 358 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. U. Goebel, P. J. Mills, M. R. Irwin, and M. G. Ziegler Interleukin-6 and Tumor Necrosis Factor-{alpha} Production After Acute Psychological Stress, Exercise, and Infused Isoproterenol: Differential Effects and Pathways Psychosom Med, July 1, 2000; 62(4): 591 - 598. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
